CI The Cigna Group Common Stock
NYSE · Health Care · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Tem 30, 2026CI Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
CI Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 05 Haziran 2007 | 3-for-1 | İleri |
| 18 Mayıs 1998 | 3-for-1 | İleri |
The Cigna Group Common Stock Hakkında Wikipedia'dan şirket genel bakışı
The Cigna Group is an American multinational for-profit managed healthcare and insurance company based in Bloomfield, Connecticut. Cigna's insurance subsidiaries are major providers of medical, dental, disability, life and accident insurance and related products and services, the majority of which are offered through employers and other groups (e.g., governmental and non-governmental organizations, unions and associations).
Cigna is incorporated in Delaware. The company ranked No. 15 in the 2023 Fortune 500 list of the largest U.S. corporations by total revenue, and the company took 68th place in the 2023 Forbes Global 2000 ranking. It has been embroiled in controversies, including engaging in automatic denials of insurance claims without reviewing them.
History
Cigna was formed by the 1982 merger of the Connecticut General Life Insurance Company (CG) and INA Corporation (the parent corporation of Insurance Company of North America, the first stock insurance company in America). The company name, Cigna, is a mix of letters from the merging companies, CG and INA. Insurance Company of North America was formed in 1792, while CG was created in 1865 by a special act of the Governor of Connecticut. In October 1871, the great Chicago Fire burned for two days, destroyed 2,000 acres, and left 100,000 people in Illinois homeless. INA paid $650,000, one of only 51 insurance companies (out of a total of 202) to pay claims in full.
Cigna sold the majority of its life insurance operations to Lincoln National Corporation in 1997.
In October 2011, Cigna agreed to buy HealthSpring Inc. for $3.8 billion to jump-start its business selling Medicare plans from 46,000 Medicare Advantage members to almost 400,000 Medicare Advantage members. The payment would come from an issue of new equity to cover about 20 percent of the value, with the rest funded by additional cash and debt. In 2013, Cigna operated in 30 countries, had approximately 35,800 employees and managed around US$53.734 billion in assets.
In June 2015, U.S. health insurer Anthem Inc. announced that it would acquire Cigna for $47 billion in cash and stock. Anthem confirmed it had reached a deal to buy Cigna on July 24, 2015. On July 21, 2016, the US Justice Department filed an antitrust suit to block the proposed merger, and a District Court ruling on February 8, 2017, blocked the merger on anticompetitive grounds. That month, Cigna Corp. called off its $48 billion merger agreement with Anthem Inc., with Anthem stating it would "continue to enforce its rights under the merger agreement and remains committed to closing the transaction." After exhausting federal appeals of the antitrust merger block, the companies turned on each other in Delaware's Court of Chancery. The legal saga came to an end with an August 31, 2020 decision denying both companies claims for compensation from the other for the failed merger.
On March 7, 2018, it was announced that Cigna would acquire Express Scripts in a $67 billion deal and on August 24, 2018, the shareholders of Cigna and Express Scripts approved the deal.
In June 2020, Cigna formed a strategic alliance with Priority Health to make comprehensive health care coverage more affordable and accessible to Michigan employers and customers.
In September 2020, Cigna rebranded its health services portfolio under the name Evernorth, which included Express Scripts, Accredo, and eviCore.
In October 2020, it was announced that Cigna and Envision Healthcare had renewed their agreement to include Envision's clinicians as in-network providers for Cigna's members. In 2021, Molina Healthcare acquired Cigna's Medicaid contracts in Texas for US$60 million.
On February 13, 2023, Cigna renamed its holding company The Cigna Group, its health benefits provider business unit Cigna Healthcare, and its Evernorth business unit Evernorth Health Services.
In January 2024, the company agreed with the Health Care Service Corporation (HCSC) to sell Cigna Group's Medicare Advantage, Cigna Supplemental Benefits, Medicare Part D, and CareAllies businesses. The total value of the transaction is about $3.7 billion. The deal also included a four-year service agreement under which Evernorth Health Services, a subsidiary of the Cigna Group, will continue to provide pharmacy benefits to Medicare beneficiaries. The deal closed on March 19, 2025.
On 8 July 2025, HCSC announced that its newly acquired Cigna Medicare Advantage products will be renamed Healthspring, which was a dormant brand name acquired as part of HCSC deal with the Cigna Group. A logo and website for the newly revived Healthspring brand have already been launched by HCSC, which now owns Healthspring.
Cigna Global Health Benefits
Cigna Global Health Benefits is a business unit within Cigna. The company is headquartered in Wilmington, Delaware, close to Philadelphia. Additional Cigna Global Health Benefits operations are located in Visalia, California, and Greenock, Scotland and Shanghai, China and Antwerp, Belgium. Sales offices are located in North America, Europe, Asia and the Middle East.
Products and services
CGHB global health plans typically include medical, dental, behavioral, and disability coverage, as well as business travel and life insurance components. Expatriates are defined as employees of multinational companies who work outside their home country on short- or long-term international assignments. CGHB maintains its own, in-house international claims platform, and offers a network of physicians and hospitals for its members (including 550,000 in the U.S. and more than 141,000 outside the U.S.).
Public relations and lobbying
Cigna spent more than $4.4 million from 2005 to 2009 on lobbying to attain legislation that the company favors. This includes $720,000 spent in 2009 alone, when it had 20 lobbyists at five firms working on its behalf.
In 2008, the head of Cigna's public relations, Wendell Potter, resigned, becoming a whistleblower who gave testimony in 2009 to the U.S. Senate Committee on Commerce, Science and Transportation in favor of reform of the health care industry.
Controversies
Automatically rejecting claims with no review
In 2023, Cigna was criticized for allowing company doctors to reject claims even if they had not opened the patient's file. The company was found to be using a system, "PXDX," that, according to ProPublica, "saved money in two ways. It allowed Cigna to begin turning down claims that it had once paid. And it made it cheaper to turn down claims, because the company's doctors never had to open a file or conduct any in-depth review. They simply denied the claims in bulk with an electronic signature." The speed with which denials were placed was termed internally as "click and close."
Nataline Sarkisyan liver transplant case
In December 2007, Cigna refused to pay for a liver transplant of a California teenage girl, Nataline Sarkisyan, coming under scrutiny as a result. There was a liver ready and waiting to be transplanted, and doctors estimated she had a 65% chance of surviving at least six months. In response to much protest and public scrutiny, Cigna reversed its decision, though Ms. Sarkisyan died awaiting the transplant.
Even though liver transplants have been performed since 1963 and are a well-accepted treatment option for end-stage liver disease and acute liver failure, Cigna defended its actions by claiming that there was insufficient data to show that a transplant for a patient in Sarkisyan's condition would be safe and effective. The California court agreed with Cigna's position that the Sarkisyans’ claims regarding Cigna's decision-making were preempted by federal ERISA law. On April 16, 2009, the United States District Court for the Central District of California dismissed all of the claims against Cigna related to the coverage determination.
The UK newspaper The Guardian in their Esc and Ctrl videoblog about control of the Internet by corporations, documented the incident with Nataline Sarkisyan and the former vice president of Cigna talking about astroturfing, the practice of creating fake blogs by interested groups, e.g. health insurance companies, to push claims that are profitable for said company into media, e.g. dismissing universal health care.
Other controversies
In 2002, Cigna was alleged in violation of the Securities Exchange Act for earnings manipulation. Its common stock price plummeted significantly as a result.
In 2015, the American Consumer Satisfaction Index named Cigna as one of the most hated companies in the U.S. Cigna's name returned on the ACSI's most hated list in 2018.
In August 2020, the Department of Justice filed a lawsuit against Cigna alleging that the company defrauded Medicare Advantage, Medicare, and Medicaid for $1.4B by submitting diagnostic codes for health conditions that patients did not have.
In November 2020, investors sued Cigna's CEO and board, alleging that they had used "black-ops-style" tactics to "blow up" the potential merger with Anthem in 2017. One pension fund accused Cigna CEO David Cordani of seeking to poison the deal after he had failed to secure the top post in the resulting company. The fund claimed he had utilized lawyers and public relations specialists to set up a "Trojan Horse" campaign. The merger would have produced the largest U.S. health insurer in 2017.
Evaluations
Cigna received gold in the 2009 Gartner & 1to1 Customer Experience Excellence Award. The awards are given to the companies that "most clearly demonstrate exemplary customer relationship strategy and an unrivaled level of excellence in delivering the customer experience".
In January 2010, Cigna received the JD Power award for customer service for all of its call centers for the fourth time in a row.
In 2011, the California Nurses Association determined that Cigna denied roughly 39.6% of all claims (compared to competitors such as Aetna, who denied about 5.9% of all claims in the same time frame).
Strategic alliances
On April 16, 2010, Cigna announced an alliance with Humana group to offer a streamlined Medicare Advantage offering through employer clients for retirees. In November 2023, Reuters reported that Cigna and Humana were in talk to merge, in a deal totalling $60 billion. In December 2023, The Wall Street Journal reported that merger talks ended.
In November 2011, Cigna and TTK Group, an Indian business conglomerate focused on healthcare, formed a joint venture called Cigna TTK to develop a health insurance business in India, subject to obtaining government approvals.
Kaynak: Wikipedia (İngilizce), CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | CI | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | 11.25Y ort. ≈16.5 | ≈16.5 | 23.3 | Düşük değerli | |
| P/S (F/S) | 0.35Y ort. ≈0.4 | ≈0.4 | 1.3 | Düşük değerli | |
| P/B (F/D) | 1.75Y ort. ≈1.9 | ≈1.9 | 2.9 | Düşük değerli | |
| EV / EBITDA | 5.25Y ort. ≈6.5 | ≈6.5 | 11.4 | Düşük değerli | |
| Price / Cash Flow (Fiyat / Nakit Akışı) | 7.45Y ort. ≈8.8 | ≈8.8 | 9.8 | Düşük değerli | |
| EV / Revenue (EV / Gelir) | 0.25Y ort. ≈0.4 | ≈0.4 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | CI | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Faaliyet Kâr Marjı (TTM) | 3.5%5Y ort. ≈4.2% | ≈4.2% | 8.3% | Zayıf | |
| FAVÖK Marjı (TTM) | 4.5%5Y ort. ≈5.5% | ≈5.5% | 8.8% | Zayıf | |
| Vergi Öncesi Kar Marjı (TTM) | 3.1%5Y ort. ≈3.3% | ≈3.3% | 3.8% | Zayıf | |
| Net Kâr Marjı (TTM) | 2.2%5Y ort. ≈2.7% | ≈2.7% | 5.1% | Zayıf | |
| ROA (TTM) | 4.0%5Y ort. ≈3.6% | ≈3.6% | 4.0% | Aynı seviyede | |
| ROE (TTM) | 15.0%5Y ort. ≈12.1% | ≈12.1% | 12.5% | Aynı seviyede | |
| ROIC | 17.8%5Y ort. ≈15.9% | ≈15.9% | 9.2% | En üst düzey |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | CI | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Borç / Öz Sermaye (MRQ) | 0.05Y ort. ≈0.0 | ≈0.0 | 0.4 | Düşük borç | |
| Cari Oran (MRQ) | 0.85Y ort. ≈0.8 | ≈0.8 | 1.4 | Düşük likidite | |
| Cari Oran (MRQ) | 0.75Y ort. ≈0.6 | ≈0.6 | 0.8 | Düşük likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | CI | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | 11.2%5Y ort. ≈11.6% | ≈11.6% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | 15.0%5Y ort. ≈11.4% | ≈11.4% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | 11.4% | · | · | · | |
| EPS YoY (EPS YB) | 83.0%5Y ort. ≈7.7% | ≈7.7% | · | · | |
| Net Income YoY (Net Gelir Yıllık Bazda) | 73.5%5Y ort. ≈1.0% | ≈1.0% | · | · | |
| EPS CAGR 3Y (EPS Bileşik Yıllık Büyüme Oranı 3Y) | 1.2%5Y ort. ≈-5.3% | ≈-5.3% | · | · | |
| EPS CAGR 5Y (EPS Bileşik Yıllık Büyüme Oranı 5Y) | -0.69% | · | · | · | |
| Net Income CAGR 3Y (Net Gelir Bileşik Yıllık Büyüme Oranı 3Y) | -4.2%5Y ort. ≈-11.2% | ≈-11.2% | · | · | |
| Net Income CAGR 5Y (Net Gelir Bileşik Yıllık Büyüme Oranı 5Y) | -6.8% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | CI | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 1.85Y ort. ≈1.4 | ≈1.4 | 1.2 | En üst düzey | |
| Inventory Turnover (Stok Devir Hızı) | 30.65Y ort. ≈29.9 | ≈29.9 | 15.6 | En üst düzey | |
| Receivables Turnover (Alacak Devir Hızı) | 10.45Y ort. ≈11.5 | ≈11.5 | 10.5 | Aynı seviyede | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$4.2M | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Temettüler Temettü verimi, ödeme oranı, temettü geçmişi, 5 Yıllık CAGR
| Ex-tarihi | Miktar | Para Birimi | Temettü Verimi |
|---|---|---|---|
| Eyl 8, 2026 | $1,56 | USD | ≈2.2% |
| Haz 4, 2026 | $1,56 | USD | ≈2.2% |
| Mar 5, 2026 | $1,56 | USD | ≈2.2% |
| Ara 4, 2025 | $1,51 | USD | ≈2.3% |
| Eyl 4, 2025 | $1,51 | USD | ≈2.0% |
| Haz 3, 2025 | $1,51 | USD | ≈1.9% |
| Mar 5, 2025 | $1,51 | USD | ≈1.8% |
| Ara 4, 2024 | $1,40 | USD | ≈1.7% |
| Eyl 4, 2024 | $1,40 | USD | ≈1.5% |
| Haz 4, 2024 | $1,40 | USD | ≈1.6% |
| Mar 5, 2024 | $1,40 | USD | ≈1.5% |
| Ara 5, 2023 | $1,23 | USD | ≈1.9% |
| Eyl 5, 2023 | $1,23 | USD | ≈1.7% |
| Haz 6, 2023 | $1,23 | USD | ≈1.8% |
| Mar 7, 2023 | $1,23 | USD | ≈1.6% |
| Ara 5, 2022 | $1,12 | USD | ≈1.4% |
| Eyl 6, 2022 | $1,12 | USD | ≈1.5% |
| Haz 7, 2022 | $1,12 | USD | ≈1.6% |
| Mar 8, 2022 | $1,12 | USD | ≈1.8% |
| Ara 6, 2021 | $1,00 | USD | ≈1.9% |
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Tem 29, 2026 | $7.78 | $7.83 | -0.59% |
| 31 Mart 2026 | $7.79 | $7.84 | -0.65% | |
| 31 Aralık 2025 | $8.08 | $8.11 | -0.41% | |
| 30 Eylül 2025 | $7.83 | $7.88 | -0.60% | |
| 30 Haziran 2025 | $7.20 | $7.37 | -2.3% | |
| 31 Mart 2025 | $6.74 | $6.54 | 3.0% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $274.90B | $247.12B | $195.26B | $180.52B | $174.07B | $160.40B | $153.57B | $48.65B | $41.81B | $39.84B | |
| Cost of Revenue | $214.99B | $182.51B | $133.80B | $124.83B | $117.55B | $103.48B | $97.67B | $4.79B | $2.46B | $2.47B | |
| SG&A Expense | $14.62B | $14.84B | $14.82B | $13.17B | $13.01B | $14.07B | $14.05B | $11.93B | $10.03B | $9.79B | |
| Operating Income | $9.20B | $9.42B | $8.54B | $8.45B | $7.94B | $8.15B | $8.08B | $4.16B | $3.94B | $3.09B | |
| Other Non-op | $-1.41B | $-1.44B | $-1.45B | $-1.23B | $-1.21B | $-1.44B | $-1.68B | $-498M | $-252M | $-278M | |
| Pretax Income | $7.78B | $5.27B | $5.51B | $8.40B | $6.79B | $10.87B | $6.57B | $3.58B | $3.61B | $2.98B | |
| Income Tax | $1.49B | $1.49B | $141M | $1.61B | $1.37B | $2.38B | $1.45B | $935M | $1.37B | $1.14B | |
| Net Income | $5.96B | $3.43B | $5.16B | $6.78B | $5.42B | $8.49B | $5.12B | $2.65B | $2.23B | $1.84B | |
| EPS (Basic) | $22.33 | $12.25 | $17.57 | $21.66 | $15.89 | $23.17 | $13.58 | $10.69 | $8.92 | $7.31 | |
| EPS (Diluted) | $22.18 | $12.12 | $17.39 | $21.41 | $15.75 | $22.96 | $13.44 | $10.54 | $8.77 | $7.19 | |
| Shares (Diluted) | 268,563,000 | 283,218,000 | 296,882,000 | 313,065,000 | 340,966,000 | 368,389,000 | 379,817,000 | 250,225,000 | 255,072,000 | 259,647,000 | |
| EBITDA | $11.97B | $12.19B | $11.57B | $11.35B | $10.86B | $10.96B | $11.73B | $4.86B | · | · |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7.68B | $7.55B | $7.82B | $5.92B | $5.08B | $10.18B | $4.62B | $3.85B | $2.97B | $3.19B | |
| Short-term Investments | $1.06B | $665M | $925M | $905M | $920M | $1.33B | $937M | $2.04B | $2.14B | · | |
| Receivables | $28.77B | $24.23B | $17.72B | $17.22B | $15.07B | $12.19B | $10.72B | $10.47B | $3.15B | · | |
| Inventory | $7.34B | $6.69B | $5.64B | $4.78B | $3.72B | $3.17B | $2.66B | $2.82B | $228M | · | |
| Other Current Assets | $2.98B | $2.73B | $2.17B | $1.30B | $1.28B | $930M | $1.40B | $1.24B | $820M | · | |
| Current Assets | $47.81B | $48.87B | $37.35B | $30.12B | $36.13B | $27.80B | $29.84B | $20.43B | $9.31B | · | |
| PP&E (Net) | $3.65B | · | · | $3.77B | $3.69B | $4.21B | $4.42B | $4.56B | $1.56B | · | |
| PP&E (Gross) | $13.75B | · | · | $11.20B | $10.28B | $9.78B | $8.92B | $7.96B | $4.61B | · | |
| Accum. Depreciation | $10.10B | · | · | $7.43B | $6.59B | $5.58B | $4.50B | $3.40B | $3.05B | · | |
| Goodwill | $44.92B | $44.37B | $44.26B | $45.81B | $45.81B | $44.65B | $44.60B | $44.51B | $6.16B | $5.98B | |
| Intangibles | $28.56B | $29.42B | $30.86B | $32.49B | $34.10B | $35.18B | $36.56B | $39.00B | $345M | · | |
| Other Non-current Assets | $2.88B | $2.79B | $3.42B | $2.70B | $3.40B | $2.69B | $2.28B | $1.63B | $1.43B | · | |
| Total Assets | $157.92B | $155.88B | $152.76B | $143.88B | $154.89B | $155.45B | $155.77B | $153.23B | $61.76B | · | |
| Accounts Payable | $10.66B | $9.29B | $8.55B | $7.78B | $6.66B | $5.48B | $5.09B | $4.37B | $184M | · | |
| Short-term Debt | $0 | $880M | $1.24B | $0 | $2.03B | $1.03B | $944M | $1.50B | $100M | · | |
| Current Liabilities | $56.34B | $57.98B | $48.72B | $41.23B | $43.57B | $36.02B | $40.14B | $31.89B | $11.01B | · | |
| Capital Leases | · | · | $340M | $346M | · | $491M | $465M | · | · | · | |
| Deferred Tax | $7.14B | $6.97B | $7.17B | $7.79B | $8.35B | $8.94B | $9.39B | $9.45B | $0 | · | |
| Other Non-current Liabilities | $4.24B | $3.21B | $3.44B | $2.77B | $3.76B | $4.63B | $4.46B | $3.47B | $2.84B | · | |
| Total Liabilities | $116.05B | $114.64B | $106.41B | $99.13B | $107.70B | $105.06B | $110.39B | $112.15B | $48.00B | · | |
| Long-term Debt | · | · | · | · | · | · | · | $39.52B | · | · | |
| Total Debt | $0 | $880M | $1.24B | $0 | $2.03B | $1.03B | $944M | $1.50B | · | · | |
| Common Stock | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $74M | · | |
| Retained Earnings | $47.87B | $43.52B | $41.65B | $37.94B | $32.59B | $28.57B | $20.16B | $15.09B | $15.80B | · | |
| Treasury Stock | $35.14B | $31.44B | $24.24B | $21.84B | $14.18B | $6.37B | $2.19B | $104M | $4.02B | · | |
| AOCI | $-2.81B | $-2.34B | $-1.86B | $-1.66B | $-884M | $-861M | $-941M | $-1.71B | $-1.08B | · | |
| Stockholders' Equity | $41.71B | $41.03B | $46.22B | $44.67B | $47.11B | $50.32B | $45.34B | $41.03B | $13.71B | · | |
| Liabilities + Equity | $157.92B | $155.88B | $152.76B | $143.88B | $154.89B | $155.45B | $155.77B | $153.23B | $61.76B | · | |
| Shares Outstanding | 263,464,000 | 273,789,000 | 292,504,000 | 298,676,000 | 322,948,000 | 354,771,000 | 372,531,000 | 380,924,000 | 0 | 0 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2.77B | $2.77B | $3.04B | $2.94B | $2.92B | $2.80B | $3.65B | $695M | $566M | $610M | |
| Deferred Tax | $326M | $-95M | $-1.66B | $-472M | $-216M | $-386M | $-313M | $-101M | $242M | $74M | |
| Amort. of Intangibles | $1.74B | $1.70B | $1.82B | $1.88B | $2.00B | $1.98B | $2.95B | $235M | $115M | $151M | |
| Restructuring | · | $0 | $252M | $22M | $168M | · | · | · | · | · | |
| Other Non-cash | $543M | $3.90B | $5.07B | $-547M | $-927M | $-555M | $1.03B | $530M | · | · | |
| Operating Cash Flow | $9.60B | $10.36B | $11.81B | $8.66B | $7.19B | $10.35B | $9.48B | $3.77B | $4.09B | $4.03B | |
| CapEx | · | · | · | · | · | · | $1.05B | $528M | $471M | $461M | |
| Investing Cash Flow | $-4.41B | $-2.10B | $-5.17B | $3.10B | $-3.61B | $2.98B | $-734M | $-26.38B | $-1.70B | $-2.57B | |
| Debt Issued | $4.46B | $4.46B | $1.49B | $0 | $4.26B | $3.46B | $0 | $22.86B | $1.58B | $0 | |
| Net Debt Issued | $261M | $1.46B | $-1.48B | $-500M | $-318M | $-4.58B | $-4.49B | $22.73B | · | · | |
| Stock Issued | $203M | $305M | $187M | $389M | $326M | $376M | $224M | $68M | $131M | $36M | |
| Stock Repurchased | $3.62B | $7.03B | $2.28B | $7.61B | $7.74B | $4.04B | $1.99B | $342M | $2.73B | $139M | |
| Net Stock Activity | $-3.42B | $-6.73B | $-2.10B | $-7.22B | $-7.42B | $-3.67B | $-1.76B | $-274M | · | · | |
| Dividends Paid | $1.61B | $1.57B | $1.45B | $1.38B | $1.34B | $15M | $15M | · | · | · | |
| Financing Cash Flow | $-6.42B | $-7.65B | $-4.29B | $-11.24B | $-8.21B | $-8.53B | $-7.19B | $23.52B | $-2.65B | $-225M | |
| Net Change in Cash | $-1.20B | $594M | $2.36B | $428M | $-4.70B | $4.83B | $1.56B | $883M | $-213M | $1.22B | |
| Taxes Paid | $399M | $898M | $1.47B | $1.85B | $2.24B | $1.84B | $1.78B | $1.02B | $1.04B | $1.06B | |
| Free Cash Flow | · | · | · | · | · | · | $8.44B | $3.24B | · | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 3.4% | 3.8% | 4.4% | 4.7% | 4.6% | 5.1% | 5.3% | 8.6% | · | · | |
| Net Margin | 2.2% | 1.5% | 2.8% | 3.7% | 3.1% | 5.3% | 3.3% | 5.4% | · | · | |
| Pretax Margin | 2.8% | 2.1% | 2.8% | 4.6% | 3.9% | 6.8% | 4.3% | 7.4% | · | · | |
| EBITDA Margin | 4.4% | 4.9% | 5.9% | 6.3% | 6.2% | 6.8% | 7.6% | 10.0% | · | · | |
| ROA | 3.8% | 2.5% | 3.6% | 4.5% | 3.5% | 5.5% | 3.3% | 2.5% | · | · | |
| ROE | 14.4% | 8.7% | 11.8% | 14.7% | 11.1% | 17.8% | 11.9% | 9.7% | · | · | |
| ROIC | 17.8% | 16.1% | 17.5% | 15.1% | 12.9% | 12.4% | 13.6% | 7.2% | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 0.8 | 0.8 | 0.7 | 0.8 | 0.8 | 0.7 | 0.6 | · | · | |
| Quick Ratio | 0.7 | 0.6 | 0.5 | 0.6 | 0.5 | 0.7 | 0.4 | 0.5 | · | · | |
| Debt / Equity | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.8 | 1.6 | 1.3 | 1.2 | 1.1 | 1.0 | 1.0 | 0.5 | · | · | |
| Inventory Turnover | 30.6 | 29.6 | 25.7 | 29.4 | 34.1 | 35.5 | 35.6 | 3.1 | · | · | |
| Receivables Turnover | 10.4 | 11.8 | 11.2 | 11.2 | 12.8 | 14.0 | 14.5 | 7.1 | · | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $158.33 | $149.87 | $158.03 | $150.24 | $145.88 | $141.84 | $121.70 | $107.71 | · | · | |
| Revenue / Share | $1023.60 | $872.55 | $657.72 | $576.61 | $510.54 | $435.41 | $404.32 | $194.43 | · | · | |
| Cash Flow / Share | $35.75 | $36.59 | $39.79 | $27.65 | $21.09 | $28.10 | $24.97 | $15.07 | · | · | |
| Cash / Share | $29.13 | $27.58 | $26.74 | $19.83 | $15.73 | $28.70 | $12.40 | $10.12 | · | · | |
| Dividend / Share | $6.04 | $5.60 | $4.92 | $4.48 | $4.00 | $0.04 | $0.04 | $0.04 | $0.04 | · | |
| EPS (TTM) | $22.18 | $12.12 | $17.39 | $21.41 | $15.75 | $22.96 | $13.44 | $10.54 | · | · |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 11.2% | 26.6% | 8.2% | 3.7% | 8.5% | · | · | · | · | · | |
| Revenue CAGR 3Y | 15.0% | 12.4% | 6.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.4% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 83.0% | -30.3% | -18.8% | 35.9% | -31.4% | · | · | · | · | · | |
| EPS CAGR 3Y | 1.2% | -8.4% | -8.8% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -0.69% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 73.5% | -33.5% | -23.9% | 25.1% | -36.1% | · | · | · | · | · | |
| Net Income CAGR 3Y | -4.2% | -14.1% | -15.3% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -6.8% | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 154.8% | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $274.90B | $247.12B | $195.26B | $180.52B | $174.07B | $160.40B | $153.57B | $48.65B | · | · | |
| Net Income TTM | $5.96B | $3.43B | $5.16B | $6.78B | $5.42B | $8.49B | $5.12B | $2.65B | · | · | |
| Market Cap | $72.51B | $75.60B | $87.59B | $98.96B | $74.16B | $73.86B | $76.18B | $72.35B | · | · | |
| Enterprise Value | $63.78B | $68.27B | $80.08B | $92.13B | $70.18B | $63.37B | $71.57B | $67.95B | · | · | |
| P/E | 12.4 | 22.8 | 17.2 | 15.5 | 14.6 | 9.1 | 15.2 | 18.0 | · | · | |
| P/S | 0.3 | 0.3 | 0.4 | 0.5 | 0.4 | 0.5 | 0.5 | 1.5 | · | · | |
| P/B | 1.7 | 1.8 | 1.9 | 2.2 | 1.6 | 1.5 | 1.7 | 1.8 | · | · | |
| P / Cash Flow | 7.6 | 7.3 | 7.4 | 11.4 | 10.3 | 7.1 | 8.0 | 19.2 | · | · | |
| P / FCF | · | · | · | · | · | · | 9.0 | 22.3 | · | · | |
| EV / EBITDA | 5.3 | 5.6 | 6.9 | 8.1 | 6.5 | 5.8 | 6.1 | 14.0 | · | · | |
| EV / FCF | · | · | · | · | · | · | 8.5 | 21.0 | · | · | |
| EV / Revenue | 0.2 | 0.3 | 0.4 | 0.5 | 0.4 | 0.4 | 0.5 | 1.4 | · | · | |
| Dividend Yield | 2.2% | 2.1% | 1.7% | 1.4% | 1.8% | 0.02% | 0.02% | · | · | · | |
| Earnings Yield | 8.1% | 4.4% | 5.8% | 6.5% | 6.9% | 11.0% | 6.6% | 5.5% | · | · | |
| Payout Ratio | 27.0% | 41.5% | 27.0% | 20.5% | 24.8% | · | · | · | · | · | |
| Annual Payout | $1.61B | $1.57B | $1.45B | $1.38B | $1.34B | $15M | $15M | · | · | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $71.67B | $68.49B | $72.47B | $69.75B | $67.18B | $65.50B | $65.65B | $63.69B | $60.52B | $57.26B | $51.11B | $49.05B | $48.59B | $46.52B | $45.75B | $45.28B | |
| Cost of Revenue | $56.70B | $54.10B | $57.80B | $55.53B | $53.27B | $48.40B | $49.02B | $47.56B | $44.49B | $41.43B | $35.26B | $33.64B | $33.44B | $31.46B | $32.09B | $31.78B | |
| SG&A Expense | $3.47B | $3.72B | $3.61B | $3.36B | $3.43B | $4.21B | $3.87B | $3.59B | $3.68B | $3.71B | $4.06B | $3.79B | $3.43B | $3.54B | $3.48B | $3.15B | |
| Operating Income | $2.68B | $2.36B | $2.35B | $2.58B | $2.31B | $1.97B | $2.17B | $2.58B | $2.41B | $2.26B | $2.06B | $2.24B | $2.22B | $2.02B | $1.75B | $2.14B | |
| Other Non-op | $-356M | $-357M | $-362M | $-347M | $-337M | $-362M | $-362M | $-376M | $-375M | $-322M | $-360M | $-365M | $-363M | $-358M | $-324M | $-304M | |
| Pretax Income | $2.26B | $2.27B | $1.82B | $2.29B | $2.02B | $1.65B | $2.01B | $1.19B | $1.99B | $79M | $188M | $1.84B | $1.88B | $1.60B | $1.36B | $3.49B | |
| Income Tax | $382M | $409M | $543M | $322M | $389M | $239M | $473M | $367M | $360M | $291M | $-919M | $391M | $374M | $295M | $136M | $713M | |
| Net Income | $1.66B | $1.65B | $943M | $1.97B | $1.53B | $1.32B | $1.19B | $825M | $1.63B | $-212M | $899M | $1.45B | $1.51B | $1.31B | $1.22B | $2.78B | |
| EPS (Basic) | $6.31 | $6.30 | $4.67 | $7.02 | $5.76 | $4.88 | $5.06 | $2.65 | $5.51 | $-0.97 | $3.54 | $4.79 | $4.96 | $4.28 | $3.89 | $9.07 | |
| EPS (Diluted) | $6.29 | $6.26 | $4.64 | $6.98 | $5.71 | $4.85 | $5.01 | $2.63 | $5.45 | $-0.97 | $3.49 | $4.74 | $4.92 | $4.24 | $3.82 | $8.97 | |
| Shares (Diluted) | 263,962,000 | 264,017,000 | · | 267,530,000 | 268,154,000 | 272,953,000 | · | 281,396,000 | 284,052,000 | 286,465,000 | · | 297,131,000 | 296,879,000 | 298,999,000 | · | 307,517,000 | |
| EBITDA | $3.33B | $3.01B | · | $3.27B | $2.99B | $2.65B | · | $2.58B | $2.41B | $3.00B | · | $2.24B | $2.22B | $2.76B | · | $2.14B |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $6.30B | $7.04B | $7.68B | $6.03B | $4.33B | $8.33B | $7.55B | $5.89B | $6.79B | $8.44B | · | $8.50B | $9.59B | $7.93B | · | $7.08B | |
| Short-term Investments | $959M | $812M | $1.06B | $883M | $813M | $727M | $665M | $864M | $1.07B | $1.11B | · | $1.05B | $872M | $914M | · | $783M | |
| Receivables | $30.80B | $26.61B | $28.77B | $31.71B | $31.15B | $26.93B | $24.23B | $27.85B | $25.11B | $20.56B | · | $19.08B | $18.33B | $17.70B | · | $17.27B | |
| Inventory | $5.85B | $5.83B | $7.34B | $5.63B | $5.97B | $5.18B | $6.69B | $5.08B | $5.17B | $4.63B | · | $4.42B | $4.51B | $4.21B | · | $4.02B | |
| Other Current Assets | $3.09B | $2.74B | $2.98B | $2.49B | $2.47B | $2.39B | $2.73B | $2.67B | $2.66B | $2.26B | · | $1.48B | $1.41B | $1.26B | · | $1.02B | |
| Current Assets | $46.99B | $43.03B | $47.81B | $46.73B | $44.72B | $43.55B | $48.87B | $49.22B | $46.22B | $43.36B | · | $34.52B | $34.71B | $32.03B | · | $30.17B | |
| PP&E (Net) | · | · | $3.65B | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| PP&E (Gross) | · | · | $13.75B | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $10.10B | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Goodwill | $45.53B | $45.53B | $44.92B | $44.92B | $44.38B | $44.37B | $44.37B | $44.37B | $44.26B | $44.26B | $44.26B | $45.81B | $45.81B | $45.81B | $45.81B | $45.81B | |
| Intangibles | $26.93B | $27.32B | $28.56B | $28.98B | $28.67B | $29.05B | $29.42B | $29.79B | $30.18B | $30.49B | · | $31.32B | $31.71B | $32.10B | · | $32.88B | |
| Other Non-current Assets | $3.32B | $3.25B | $2.88B | $3.39B | $2.93B | $3.00B | $2.79B | $3.18B | $3.28B | $3.29B | · | $3.15B | $2.50B | $2.56B | · | $2.48B | |
| Total Assets | $157.08B | $153.27B | $157.92B | $157.92B | $151.65B | $150.66B | $155.88B | $157.64B | $155.45B | $153.12B | · | $149.65B | $150.05B | $147.98B | · | $144.21B | |
| Accounts Payable | $10.41B | $9.88B | $10.66B | $9.35B | $9.94B | $9.14B | $9.29B | $8.52B | $9.28B | $8.12B | · | $7.67B | $8.07B | $7.36B | · | $6.87B | |
| Short-term Debt | $1.00B | · | $0 | · | · | $0 | $880M | $1.64B | $790M | $884M | · | $1.51B | $200M | · | · | $0 | |
| Current Liabilities | $55.56B | $52.61B | $56.34B | $56.45B | $56.78B | $55.74B | $57.98B | $57.06B | $55.37B | $51.98B | · | $47.06B | $47.34B | $44.73B | · | $41.12B | |
| Capital Leases | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $368M | |
| Deferred Tax | $6.73B | $6.85B | $7.14B | $7.00B | $6.78B | $6.88B | $6.97B | $6.79B | $6.95B | $7.03B | · | $7.48B | $7.59B | $7.71B | · | $7.78B | |
| Other Non-current Liabilities | $5.61B | $4.77B | $4.24B | $3.87B | $3.65B | $3.58B | $3.21B | $3.03B | $3.54B | $3.65B | · | $2.93B | $2.58B | $2.69B | · | $3.18B | |
| Total Liabilities | $114.17B | $110.82B | $116.05B | $115.91B | $111.22B | $110.24B | $114.64B | $115.34B | $113.92B | $111.77B | · | $103.88B | $104.53B | $103.38B | · | $99.08B | |
| Total Debt | $1.00B | · | · | · | · | $0 | · | $1.64B | $790M | $884M | · | $1.51B | $200M | · | · | $0 | |
| Common Stock | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | · | $4M | $4M | $4M | · | $4M | |
| Retained Earnings | $50.35B | $49.11B | $47.87B | $47.03B | $45.56B | $44.43B | $43.52B | $42.48B | $42.13B | $40.98B | · | $40.98B | $39.94B | $38.84B | · | $37.04B | |
| Treasury Stock | $35.47B | $35.22B | $35.14B | $34.13B | $34.13B | $33.06B | $31.44B | $29.41B | $29.41B | $27.77B | · | $23.74B | $23.05B | $22.91B | · | $19.39B | |
| AOCI | $-4.36B | $-3.60B | $-2.81B | $-2.80B | $-2.82B | $-2.59B | $-2.34B | $-2.16B | $-2.44B | $-2.32B | · | $-2.12B | $-1.88B | $-1.77B | · | $-2.01B | |
| Stockholders' Equity | $42.62B | $42.21B | $41.71B | $41.80B | $40.21B | $40.23B | $41.03B | $42.09B | $41.33B | $41.18B | · | $45.69B | $45.45B | $44.50B | · | $45.04B | |
| Liabilities + Equity | $157.08B | $153.27B | $157.92B | $157.92B | $151.65B | $150.66B | $155.88B | $157.64B | $155.45B | $153.12B | · | $149.65B | $150.05B | $147.98B | · | $144.21B | |
| Shares Outstanding | · | · | 263,464,000 | · | · | · | 273,789,000 | · | · | · | 292,504,000 | · | · | · | 298,676,000 | · |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $655M | $650M | $722M | $697M | $682M | $674M | $646M | $650M | $738M | $741M | $765M | $766M | $755M | $749M | $735M | $726M | |
| Amort. of Intangibles | $389M | $390M | $463M | $436M | $422M | $422M | $424M | $436M | $420M | $423M | $451M | $454M | $455M | $459M | $457M | $460M | |
| Restructuring | · | · | · | $222M | $129M | $215M | · | $0 | $0 | $0 | $252M | $0 | $0 | · | $0 | $0 | |
| Other Non-cash | · | $-1.17B | · | · | · | $-163M | · | · | · | $4.31B | · | · | · | $2.97B | · | · | |
| Operating Cash Flow | $-421M | $1.13B | $6.15B | $3.42B | $-1.89B | $1.92B | $5.21B | $46M | $265M | $4.84B | $1.47B | $2.83B | $2.49B | $5.03B | $2.10B | $3.28B | |
| Investing Cash Flow | $-503M | $-637M | $-420M | $-4.39B | $-797M | $1.20B | $-191M | $-776M | $-640M | $-495M | $-440M | $-1.34B | $-414M | $-2.98B | $-616M | $4.45B | |
| Debt Issued | · | · | $-3M | $4.46B | $0 | $0 | $0 | $0 | $0 | $4.46B | $0 | $0 | $0 | $1.49B | $0 | $0 | |
| Net Debt Issued | · | $-550M | · | · | · | $-700M | · | · | · | $2.25B | · | · | · | $1.41B | · | · | |
| Stock Issued | $101M | $57M | $25M | $37M | $72M | $69M | $22M | $62M | $40M | $181M | $74M | $54M | $29M | $30M | $72M | $100M | |
| Stock Repurchased | $280M | $0 | $1.00B | $0 | $1.11B | $1.51B | $2.02B | $0 | $990M | $4.02B | $544M | $624M | $154M | $962M | $1.73B | $3.50B | |
| Net Stock Activity | · | $57M | · | · | · | $-1.44B | · | · | · | $-3.84B | · | · | · | $-932M | · | · | |
| Dividends Paid | $409M | $417M | $396M | $402M | $401M | $412M | $384M | $390M | $392M | $401M | $358M | $362M | $362M | $368M | $334M | $341M | |
| Financing Cash Flow | $207M | $-1.14B | $-4.07B | $2.66B | $-1.33B | $-3.68B | $-3.25B | $439M | $-2.31B | $-2.53B | $-1.25B | $-2.57B | $-435M | $-37M | $-2.64B | $-5.52B | |
| Net Change in Cash | $-724M | $-656M | $1.67B | $1.69B | $-3.99B | $-555M | $1.75B | $-273M | $-2.69B | $1.81B | $-209M | $-1.09B | $1.65B | $2.01B | $-1.14B | $2.19B | |
| Taxes Paid | · | · | $43M | $6M | $210M | $140M | $59M | $272M | $457M | $110M | $91M | $454M | $849M | $77M | $504M | $435M |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 3.7% | 3.4% | · | 3.7% | 3.4% | 3.0% | · | 4.0% | 4.0% | 3.9% | · | 4.6% | 4.6% | 4.3% | · | 4.7% | |
| Net Margin | 2.3% | 2.4% | · | 2.8% | 2.4% | 2.1% | · | 1.3% | 2.7% | -0.37% | · | 2.9% | 3.1% | 2.8% | · | 6.1% | |
| Pretax Margin | 3.1% | 3.3% | · | 3.3% | 3.0% | 2.5% | · | 1.9% | 3.3% | 0.14% | · | 3.8% | 3.9% | 3.4% | · | 7.7% | |
| EBITDA Margin | 4.7% | 4.4% | · | 4.7% | 4.5% | 4.0% | · | 4.0% | 4.0% | 5.2% | · | 4.6% | 4.6% | 5.9% | · | 4.7% | |
| ROA | 1.1% | 1.1% | · | 1.2% | 1.1% | 0.93% | · | 0.54% | 1.1% | -0.14% | · | 0.99% | 1.0% | 0.87% | · | 1.9% | |
| ROE | 4.0% | 4.0% | · | 4.7% | 4.0% | 3.5% | · | 1.9% | 3.8% | -0.49% | · | 3.2% | 3.3% | 2.9% | · | 6.0% | |
| ROIC | 5.1% | 4.6% | · | 5.3% | 4.6% | 4.2% | · | 4.1% | 4.7% | -14.4% | · | 3.7% | 3.9% | 3.7% | · | 3.8% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 0.8 | · | 0.8 | 0.8 | 0.8 | · | 0.9 | 0.8 | 0.8 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | |
| Quick Ratio | 0.7 | 0.7 | · | 0.7 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | |
| Debt / Equity | 0.0 | · | · | · | · | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | 0.0 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Inventory Turnover | 9.6 | 9.8 | · | 10.4 | 9.6 | 9.9 | · | 10.0 | 9.2 | 9.4 | · | 8.0 | 8.1 | 8.2 | · | 9.0 | |
| Receivables Turnover | 2.3 | 2.6 | · | 2.3 | 2.4 | 2.8 | · | 2.7 | 2.8 | 3.0 | · | 2.7 | 2.7 | 2.8 | · | 2.7 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $271.51 | $259.43 | · | $260.71 | $250.52 | $239.98 | · | $226.35 | $213.07 | $199.87 | · | $165.07 | $163.66 | $155.58 | · | $147.24 | |
| Cash Flow / Share | · | $4.28 | · | · | · | $7.03 | · | · | · | $16.90 | · | · | · | $16.82 | · | · | |
| Dividend / Share | $1.56 | $1.56 | $1.51 | $1.51 | $1.51 | $1.51 | $1.40 | $1.40 | $1.40 | $1.40 | $1.23 | $1.23 | $1.23 | $1.23 | $1.12 | $1.12 | |
| EPS (TTM) | $24.17 | $23.59 | · | $22.55 | $18.20 | $17.94 | · | $10.60 | $12.71 | $12.18 | · | $17.72 | $21.95 | $21.92 | · | $20.99 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $282.38B | $277.89B | · | $268.08B | $262.02B | $255.37B | · | $232.59B | $217.94B | $206.00B | · | $189.90B | $186.14B | $183.03B | · | $180.44B | |
| Net Income TTM | $6.23B | $6.10B | · | $6.02B | $4.87B | $4.97B | · | $3.14B | $3.77B | $3.65B | · | $5.49B | $6.82B | $6.88B | · | $6.70B | |
| P/E | 11.4 | 11.3 | · | 12.8 | 18.2 | 18.3 | · | 32.7 | 26.0 | 29.8 | · | 16.1 | 12.8 | 11.7 | · | 13.2 | |
| Earnings Yield | 8.8% | 8.8% | · | 7.8% | 5.5% | 5.5% | · | 3.1% | 3.8% | 3.4% | · | 6.2% | 7.8% | 8.6% | · | 7.6% | |
| Payout Ratio | · | 25.2% | · | · | · | 29.2% | · | · | · | -189.2% | · | · | · | 28.2% | · | · | |
| Annual Payout | $1.62B | $1.62B | · | $1.60B | $1.59B | $1.58B | · | $1.54B | $1.51B | $1.48B | · | $1.43B | $1.41B | $1.40B | · | $1.37B |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $274.90B | $247.12B | $195.26B | $180.52B | $174.07B |
| Faaliyet Kâr Marjı % | 3.4% | 3.8% | 4.4% | 4.7% | 4.6% |
| Net Gelir | $5.96B | $3.43B | $5.16B | $6.78B | $5.42B |
| Seyreltilmiş Hisse Başı Kâr | $22.18 | $12.12 | $17.39 | $21.41 | $15.75 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cari Oran | 0.8 | 0.8 | 0.8 | 0.7 | 0.8 |
| Cari Oran | 0.7 | 0.6 | 0.5 | 0.6 | 0.5 |
Bu beyanı oluşturmak için henüz yeterli temel verisi yok.
Kurumsal Sahipler (13F) 1.867 dosya · $73.0B toplam · Tarih itibarıyla 30 Eylül 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 160 (-31 önceki Ç'ye göre) | 92 (-24 önceki Ç'ye göre) | 684 (+29 önceki Ç'ye göre) | 593 (+10 önceki Ç'ye göre) | +5.4M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| VANGUARD GROUP INC | $7.203.753.597 | 26.173.577 | 9,87% | Hisse senetleri |
| BlackRock, Inc. | $6.461.456.854 | 23.438.250 | 8,85% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $4.762.729.281 | 17.276.296 | 6,53% | Hisse senetleri |
| STATE STREET CORP | $3.496.245.161 | 12.682.259 | 4,79% | Hisse senetleri |
| Dodge & Cox | $3.356.093.871 | 12.173.875 | 4,60% | Hisse senetleri |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $2.895.610.431 | 10.443.691 | 3,97% | Hisse senetleri |
| Sanders Capital, LLC | $2.796.668.015 | 10.144.617 | 3,83% | Hisse senetleri |
| FMR LLC | $2.210.454.198 | 8.018.189 | 3,03% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $1.720.317.832 | 6.268.347 | 2,36% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.717.104.307 | 6.228.614 | 2,35% | Hisse senetleri |
| GQG Partners LLC | $1.628.918.123 | 5.908.707 | 2,23% | Hisse senetleri |
| JPMORGAN CHASE & CO | $1.447.877.312 | 5.194.363 | 1,98% | Hisse senetleri |
| MORGAN STANLEY | $1.017.483.597 | 3.690.812 | 1,39% | Hisse senetleri |
| NORGES BANK | $982.164.860 | 3.562.699 | 1,35% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $827.692.197 | 3.002.366 | 1,13% | Hisse senetleri |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $785.495.575 | 2.849.302 | 1,08% | Hisse senetleri |
| NORTHERN TRUST CORP | $752.795.794 | 2.730.687 | 1,03% | Hisse senetleri |
| AMERIPRISE FINANCIAL INC | $719.183.166 | 2.608.447 | 0,99% | Hisse senetleri |
| Grantham, Mayo, Van Otterloo & Co. LLC | $710.448.797 | 2.577.075 | 0,97% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $692.582.460 | 2.512.025 | 0,95% | Hisse senetleri |
| Invesco Ltd. | $662.627.873 | 2.403.612 | 0,91% | Hisse senetleri |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $656.057.221 | 2.459.446 | 0,90% | Hisse senetleri |
| Davis Selected Advisers | $621.243.564 | 2.253.424 | 0,85% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $600.668.400 | 2.178.861 | 0,82% | Hisse senetleri |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $558.018.223 | 2.024.152 | 0,76% | Hisse senetleri |
| Boston Partners | $555.607.176 | 2.014.660 | 0,76% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $548.715.710 | 1.990.408 | 0,75% | Hisse senetleri |
| Legal & General Group Plc | $542.779.462 | 1.968.875 | 0,74% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $499.838.165 | 1.813.110 | 0,68% | Hisse senetleri |
| Amundi | $472.966.222 | 1.715.636 | 0,65% | Hisse senetleri |
| Bank of New York Mellon Corp | $450.936.717 | 1.635.725 | 0,62% | Hisse senetleri |
| NORDEA INVESTMENT MANAGEMENT AB | $409.669.412 | 1.476.499 | 0,56% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $409.373.497 | 1.484.959 | 0,56% | Hisse senetleri |
| AQR CAPITAL MANAGEMENT LLC | $396.029.634 | 1.436.556 | 0,54% | Hisse senetleri |
| NATIONAL BANK OF CANADA /FI/ | $396.005.041 | 1.436.453 | 0,54% | Hisse senetleri |
| Nuveen, LLC | $372.070.579 | 1.349.647 | 0,51% | Hisse senetleri |
| Capital World Investors | $365.436.721 | 1.325.583 | 0,50% | Hisse senetleri |
| DEUTSCHE BANK AG\ | $352.569.909 | 1.278.910 | 0,48% | Hisse senetleri |
| Capital Research Global Investors | $340.312.625 | 1.234.448 | 0,47% | Hisse senetleri |
| VICTORY CAPITAL MANAGEMENT INC | $297.765.000 | 1.080.111 | 0,41% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $295.639.232 | 1.072.400 | 0,41% | Alım opsiyonu |
| RAYMOND JAMES FINANCIAL INC | $285.021.252 | 1.033.884 | 0,39% | Hisse senetleri |
| BloombergSen Inc. | $250.400.144 | 908.300 | 0,34% | Alım opsiyonu |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $241.311.801 | 875.333 | 0,33% | Hisse senetleri |
| Russell Investments Group, Ltd. | $233.022.643 | 844.481 | 0,32% | Hisse senetleri |
| BRANDES INVESTMENT PARTNERS, LP | $232.489.133 | 843.317 | 0,32% | Hisse senetleri |
| National Pension Service | $218.948.088 | 794.211 | 0,30% | Hisse senetleri |
| UBS Group AG | $213.774.402 | 775.444 | 0,29% | Hisse senetleri |
| Sumitomo Mitsui Trust Group, Inc. | $210.159.410 | 762.331 | 0,29% | Hisse senetleri |
| Swiss National Bank | $205.012.464 | 743.661 | 0,28% | Hisse senetleri |
Şirket yöneticileri 41 içeriden öğrenenler · 8 yöneticiler · 11 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Everett Neville | EVP, Special Advisor to the CEO | 03 Eylül 2026 S | 5.053 | 0 | 2 | $-671.895 |
| Brian C Evanko | President and Chief Executive Officer | 01 Eylül 2026 A | 41.030 | 0 | 1 | $-1.610.400 |
| David Cordani | Chairman & CEO | 13 Mayıs 2026 M | 57.766 | 1 | 13 | $-58.114.037 |
| Ann M Dennison | EVP, CFO | 27 Şubat 2026 A | 7.745 | 0 | 0 | $0 |
| Nicole S Jones | EVP, Chief Administrative Officer and Chief Human Resources Officer | 18 Ağustos 2026 S | 25.880 | 0 | 3 | $-6.784.615 |
| Bryan Holgerson | Title - President, Cigna Healthcare U.S. and EVP, Customer Health Outcomes | 06 Ağustos 2026 A | · | 0 | 0 | $0 |
| Jamie G Kates | Chief Accounting Officer | 12 Haziran 2026 M | 2.368 | 0 | 1 | $-268.450 |
| Durga Prasad Koka | EVP, Global CIO | 01 Haziran 2026 F | 6.552 | 0 | 0 | $0 |
| George Kurian | Yönetim kurulu üyesi | 31 Ağustos 2026 A | 4.560 | 0 | 0 | $0 |
| Neesha Hathi | Yönetim kurulu üyesi | 22 Nisan 2026 A | 4.151 | 0 | 0 | $0 |
| Philip Ozuah | Yönetim kurulu üyesi | 22 Nisan 2026 A | 2.583 | 0 | 0 | $0 |
| Mark B. Mcclellan | Yönetim kurulu üyesi | 22 Nisan 2026 A | 6.891 | 0 | 0 | $0 |
| Kimberly A. Ross | Yönetim kurulu üyesi | 22 Nisan 2026 A | 5.294 | 0 | 0 | $0 |
| Michael J Hennigan | Yönetim kurulu üyesi | 22 Nisan 2026 A | 1.350 | 0 | 0 | $0 |
| Kathleen M Mazzarella | Yönetim kurulu üyesi | 22 Nisan 2026 A | 6.891 | 0 | 0 | $0 |
| Donna F Zarcone | Yönetim kurulu üyesi | 22 Nisan 2026 A | 27.517 | 0 | 0 | $0 |
| Eric C Wiseman | Yönetim kurulu üyesi | 22 Nisan 2026 A | 23.940 | 0 | 0 | $0 |
| Eric J Foss | Yönetim kurulu üyesi | 22 Nisan 2026 A | 36.696 | 0 | 0 | $0 |
| David J Brailer | · | 29 Ağustos 2025 F | 17.525 | 0 | 0 | $0 |
| Elder Granger | · | 23 Nisan 2025 A | 6.109 | 0 | 0 | $0 |
| Noelle K Eder | · | 07 Mart 2025 S | 13.406 | 0 | 0 | $0 |
| Eric P Palmer | · | 28 Şubat 2025 A | 66.160 | 0 | 0 | $0 |
| William J Delaney III | · | 19 Ağustos 2024 M | 17.539 | 0 | 0 | $0 |
| Michael W Triplett | · | 12 Ağustos 2024 M | 32.833 | 0 | 0 | $0 |
| Mary T Hoeltzel | · | 14 Mayıs 2024 M | 2.595 | 0 | 0 | $0 |
| Cynthia Ryan | · | 30 Ağustos 2023 M | 5.937 | 0 | 0 | $0 |
| Paul A Sanford | · | 19 Temmuz 2023 S | 8.679 | 0 | 0 | $0 |
| Jason D Sadler | · | 24 Şubat 2023 A | 47.015 | 0 | 0 | $0 |
| Charles Berg | · | 08 Şubat 2023 G | · | 0 | 0 | $0 |
| John Partridge | · | 26 Nisan 2022 A | 28.177 | 0 | 0 | $0 |
| MURABITO JOHN M | · | 01 Mart 2022 F | 51.226 | 0 | 0 | $0 |
| HARRIS ISAIAH JR | · | 30 Kasım 2021 A | 20.015 | 0 | 0 | $0 |
| Matthew G Manders | · | 19 Kasım 2021 F | 43.488 | 0 | 0 | $0 |
| Timothy C Wentworth | · | 12 Mayıs 2021 G | 29.783 | 0 | 0 | $0 |
| Kristen Lauria | · | 30 Nisan 2021 F | 2.785 | 0 | 0 | $0 |
| Steven B Miller | · | 26 Şubat 2021 F | 28.439 | 0 | 0 | $0 |
| William L Roper | · | 26 Şubat 2021 A | 8.583 | 0 | 0 | $0 |
| Roman Martinez IV | · | 30 Kasım 2020 A | 48.839 | 0 | 0 | $0 |
| Mark L Boxer | · | 28 Şubat 2020 F | 49.191 | 0 | 0 | $0 |
| ZOLLARS WILLIAM D | · | 13 Eylül 2019 S | 13.500 | 0 | 0 | $0 |
| Lisa R Bacus | · | 01 Mart 2019 F | 24.024 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 156 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| IHF · iShares Trust | 4,00% | 186.760 SH | 11 Eylül 2026 | Günlük |
| DUSA · Davis Fundamental ETF Trust | 3,12% | 142.104 NS | 31 Temmuz 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 2,29% | 86.083 NS | 31 Temmuz 2026 | N-PORT |
| SMRI · EA Series Trust | 1,79% | 41.365 NS | 31 Temmuz 2026 | N-PORT |
| BMVP · Invesco Exchange-Traded Fund Trust | 1,76% | 6.426 SH | 01 Ekim 2026 | Günlük |
| RPV · Invesco Exchange-Traded Fund Trust | 1,64% | 98.965 SH | 01 Ekim 2026 | Günlük |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,60% | 51.281 SH | 01 Ekim 2026 | Günlük |
| PWV · Invesco Exchange-Traded Fund Trust | 1,49% | 99.278 SH | 01 Ekim 2026 | Günlük |
| NUDV · Nushares ETF Trust | 1,45% | 2.607 NS | 31 Temmuz 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 1,42% | 506.293 SH | 01 Ekim 2026 | Günlük |
| DWLD · Davis Fundamental ETF Trust | 1,36% | 29.890 NS | 31 Temmuz 2026 | N-PORT |
| SPGP · Invesco Exchange-Traded Fund Trust | 1,19% | 89.148 SH | 01 Ekim 2026 | Günlük |
| IYH · iShares Trust | 1,18% | 152.840 SH | 11 Eylül 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 1,07% | 792.582 SH | 19 Ağustos 2026 | Günlük |
| FHLC · FIDELITY COVINGTON TRUST | 1,06% | 125.422 NS | 31 Temmuz 2026 | N-PORT |
| IMCV · iShares Trust | 1,00% | 41.404 SH | 11 Eylül 2026 | Günlük |
| FFLV · FIDELITY COVINGTON TRUST | 0,97% | 573 NS | 31 Temmuz 2026 | N-PORT |
| REVS · Columbia ETF Trust I | 0,95% | 11.306 NS | 31 Temmuz 2026 | N-PORT |
| IXJ · iShares Trust | 0,94% | 139.115 SH | 11 Eylül 2026 | Günlük |
| RILA · Spinnaker ETF Series | 0,93% | 1.412 NS | 31 Temmuz 2026 | N-PORT |
| VLUE · iShares Trust | 0,90% | 308.315 SH | 11 Eylül 2026 | Günlük |
| FBCV · FIDELITY COVINGTON TRUST | 0,88% | 5.567 NS | 31 Temmuz 2026 | N-PORT |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 0,88% | 30.767.177 | 01 Ekim 2026 | Günlük |
| FTA · First Trust Exchange-Traded AlphaDE… | 0,87% | 43.607 NS | 31 Temmuz 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 0,85% | 5.205 NS | 31 Temmuz 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,80% | 24.655 SH | 19 Ağustos 2026 | Günlük |
| EQIN · Columbia ETF Trust I | 0,77% | 8.375 NS | 31 Temmuz 2026 | N-PORT |
| NULV · Nushares ETF Trust | 0,72% | 56.688 NS | 31 Temmuz 2026 | N-PORT |
| CVY · Invesco Exchange-Traded Fund Trust | 0,69% | 2.953 SH | 01 Ekim 2026 | Günlük |
| DFLV · Dimensional ETF Trust | 0,63% | 152.491 NS | 31 Temmuz 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,62% | 22.025 SH | 01 Ekim 2026 | Günlük |
| RECS · Columbia ETF Trust I | 0,61% | 128.339 NS | 31 Temmuz 2026 | N-PORT |
| BSCU · Invesco Exchange-Traded Self-Indexe… | 0,61% | 17.898.000 | 01 Ekim 2026 | Günlük |
| IIGD · Invesco Exchange-Traded Self-Indexe… | 0,57% | 150.000 | 01 Ekim 2026 | Günlük |
| FFLC · FIDELITY COVINGTON TRUST | 0,56% | 24.069 NS | 31 Temmuz 2026 | N-PORT |
| FDLO · FIDELITY COVINGTON TRUST | 0,55% | 28.136 NS | 31 Temmuz 2026 | N-PORT |
| FEUS · FlexShares Trust | 0,55% | 2.200 NS | 31 Temmuz 2026 | N-PORT |
| WLDR · Two Roads Shared Trust | 0,53% | 1.744 NS | 31 Temmuz 2026 | N-PORT |
| IMCB · iShares Trust | 0,50% | 29.774 SH | 11 Eylül 2026 | Günlük |
| QLC · FlexShares Trust | 0,48% | 17.472 NS | 31 Temmuz 2026 | N-PORT |
| QIDX · Spinnaker ETF Series | 0,48% | 664 NS | 31 Temmuz 2026 | N-PORT |
| FEX · First Trust Exchange-Traded AlphaDE… | 0,46% | 25.557 NS | 31 Temmuz 2026 | N-PORT |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,44% | 2.633 NS | 31 Temmuz 2026 | N-PORT |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0,43% | 560.000 | 01 Ekim 2026 | Günlük |
| BSCR · Invesco Exchange-Traded Self-Indexe… | 0,42% | 19.474.000 | 01 Ekim 2026 | Günlük |
| XOEF · iShares Trust | 0,42% | 331 SH | 11 Eylül 2026 | Günlük |
| DFUV · Dimensional ETF Trust | 0,37% | 206.037 NS | 31 Temmuz 2026 | N-PORT |
| JOYT · J.P. Morgan Exchange-Traded Fund Tr… | 0,37% | 1.294 NS | 31 Temmuz 2026 | N-PORT |
| ESMV · iShares Trust | 0,37% | 102 SH | 11 Eylül 2026 | Günlük |
| CATH · Global X Funds | 0,35% | 16.346 NS | 31 Temmuz 2026 | N-PORT |
| MGV · VANGUARD WORLD FUND | 0,34% | 166.268 SH | 19 Ağustos 2026 | Günlük |
| DGRO · iShares Trust | 0,33% | 509.486 SH | 11 Eylül 2026 | Günlük |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0,32% | 9.701 NS | 31 Temmuz 2026 | N-PORT |
| HELO · J.P. Morgan Exchange-Traded Fund Tr… | 0,32% | 52.531 NS | 31 Temmuz 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0,31% | 111.655 SH | 01 Ekim 2026 | Günlük |
| VYM · VANGUARD WHITEHALL FUNDS | 0,30% | 1.042.139 SH | 19 Ağustos 2026 | Günlük |
| EVUS · iShares Trust | 0,30% | 4.037 SH | 11 Eylül 2026 | Günlük |
| DFVX · Dimensional ETF Trust | 0,28% | 5.359 NS | 31 Temmuz 2026 | N-PORT |
| IWX · iShares Trust | 0,27% | 37.789 SH | 11 Eylül 2026 | Günlük |
| VTV · VANGUARD INDEX FUNDS | 0,27% | 2.516.218 SH | 19 Ağustos 2026 | Günlük |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,26% | 4.203 NS | 31 Temmuz 2026 | N-PORT |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,25% | 60.916 SH | 19 Ağustos 2026 | Günlük |
| IVE · iShares Trust | 0,25% | 438.897 SH | 11 Eylül 2026 | Günlük |
| DFSU · Dimensional ETF Trust | 0,25% | 20.149 NS | 31 Temmuz 2026 | N-PORT |
| VEGN · ETF Series Solutions | 0,24% | 1.532 NS | 31 Temmuz 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0,24% | 6.130 SH | 19 Ağustos 2026 | Günlük |
| IUSV · iShares Trust | 0,24% | 231.763 SH | 11 Eylül 2026 | Günlük |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 0,23% | 6.639.000 | 01 Ekim 2026 | Günlük |
| CHRI · Global X Funds | 0,22% | 64 NS | 31 Temmuz 2026 | N-PORT |
| IQSU · New York Life Investments ETF Trust | 0,22% | 2.603 NS | 31 Temmuz 2026 | N-PORT |
| SUSL · iShares Trust | 0,22% | 9.336 SH | 11 Eylül 2026 | Günlük |
| ACVF · ETF Opportunities Trust | 0,21% | 1.165 NS | 31 Temmuz 2026 | N-PORT |
| DSI · iShares Trust | 0,21% | 40.359 SH | 11 Eylül 2026 | Günlük |
| ILCV · iShares Trust | 0,21% | 9.900 SH | 11 Eylül 2026 | Günlük |
| DXUV · Dimensional ETF Trust | 0,21% | 4.094 NS | 31 Temmuz 2026 | N-PORT |
| EUSA · iShares, Inc. | 0,21% | 14.065 SH | 11 Eylül 2026 | Günlük |
| RSP · Invesco Exchange-Traded Fund Trust | 0,20% | 703.269 SH | 01 Ekim 2026 | Günlük |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,20% | 157.624 SH | 19 Ağustos 2026 | Günlük |
| IWD · iShares Trust | 0,20% | 580.231 SH | 11 Eylül 2026 | Günlük |
| ACWV · iShares, Inc. | 0,19% | 23.190 SH | 11 Eylül 2026 | Günlük |
| ESGU · iShares Trust | 0,19% | 122.944 SH | 11 Eylül 2026 | Günlük |
| ROUS · Lattice Strategies Trust | 0,19% | 4.742 NS | 31 Temmuz 2026 | N-PORT |
| MPLY · Strategy Shares | 0,18% | 104 NS | 31 Temmuz 2026 | N-PORT |
| SIZE · iShares Trust | 0,18% | 2.691 SH | 11 Eylül 2026 | Günlük |
| GLBL · Pacer Funds Trust | 0,18% | 7 NS | 31 Temmuz 2026 | N-PORT |
| USMV · iShares Trust | 0,17% | 144.573 SH | 11 Eylül 2026 | Günlük |
| EGLE · Global X Funds | 0,17% | 13 NS | 31 Temmuz 2026 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,16% | 28.208 SH | 01 Ekim 2026 | Günlük |
| DFAC · Dimensional ETF Trust | 0,15% | 249.847 NS | 31 Temmuz 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,14% | 63.351 NS | 31 Temmuz 2026 | N-PORT |
| MGC · VANGUARD WORLD FUND | 0,14% | 52.742 SH | 19 Ağustos 2026 | Günlük |
| TOPC · iShares Trust | 0,14% | 159 SH | 11 Eylül 2026 | Günlük |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,13% | 8.098 SH | 01 Ekim 2026 | Günlük |
| DIVB · iShares Trust | 0,13% | 9.546 SH | 11 Eylül 2026 | Günlük |
| IWL · iShares Trust | 0,13% | 10.119 SH | 11 Eylül 2026 | Günlük |
| XVV · iShares Trust | 0,13% | 3.041 SH | 11 Eylül 2026 | Günlük |
| VV · VANGUARD INDEX FUNDS | 0,12% | 308.954 SH | 19 Ağustos 2026 | Günlük |
| ESGV · VANGUARD WORLD FUND | 0,12% | 59.034 SH | 19 Ağustos 2026 | Günlük |
| XYLD · Global X Funds | 0,12% | 13.766 NS | 31 Temmuz 2026 | N-PORT |
| ACIO · ETF Series Solutions | 0,12% | 9.915 NS | 31 Temmuz 2026 | N-PORT |
| ADME · ETF Series Solutions | 0,11% | 1.207 NS | 31 Temmuz 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0,11% | 13.352 NS | 31 Temmuz 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,11% | 13.613 NS | 31 Temmuz 2026 | N-PORT |
| XRMI · Global X Funds | 0,11% | 203 NS | 31 Temmuz 2026 | N-PORT |
| IVV · iShares Trust | 0,11% | 3.332.808 SH | 11 Eylül 2026 | Günlük |
| BKLC · BNY Mellon ETF Trust | 0,11% | 21.844 NS | 31 Temmuz 2026 | N-PORT |
| XYLG · Global X Funds | 0,11% | 255 NS | 31 Temmuz 2026 | N-PORT |
| PBP · Invesco Exchange-Traded Fund Trust | 0,11% | 1.573 SH | 01 Ekim 2026 | Günlük |
| XTR · Global X Funds | 0,11% | 19 NS | 31 Temmuz 2026 | N-PORT |
| BBUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,11% | 35.099 NS | 31 Temmuz 2026 | N-PORT |
| VOO · VANGUARD INDEX FUNDS | 0,11% | 6.870.735 SH | 19 Ağustos 2026 | Günlük |
| TOV · EA Series Trust | 0,11% | 1.059 NS | 31 Temmuz 2026 | N-PORT |
| XCLR · Global X Funds | 0,11% | 14 NS | 31 Temmuz 2026 | N-PORT |
| VOTE · TCW ETF Trust | 0,11% | 4.302 NS | 31 Temmuz 2026 | N-PORT |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0,11% | 45.656 SH | 01 Ekim 2026 | Günlük |
| DFUS · Dimensional ETF Trust | 0,11% | 80.995 NS | 31 Temmuz 2026 | N-PORT |
| ILCB · iShares Trust | 0,11% | 4.927 SH | 11 Eylül 2026 | Günlük |
| IYY · iShares Trust | 0,11% | 11.380 SH | 11 Eylül 2026 | Günlük |
| SPUU · Direxion Shares ETF Trust | 0,11% | 998 NS | 31 Temmuz 2026 | N-PORT |
| IWB · iShares Trust | 0,10% | 180.235 SH | 11 Eylül 2026 | Günlük |
| QDPL · Pacer Funds Trust | 0,10% | 6.372 NS | 31 Temmuz 2026 | N-PORT |
| ESG · FlexShares Trust | 0,10% | 480 NS | 31 Temmuz 2026 | N-PORT |
| VOXP · Advisors Series Trust | 0,10% | 21 NS | 31 Temmuz 2026 | N-PORT |
| ITOT · iShares Trust | 0,10% | 343.920 SH | 11 Eylül 2026 | Günlük |
| IWV · iShares Trust | 0,10% | 71.744 SH | 11 Eylül 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | 0,10% | 8.400.121 SH | 19 Ağustos 2026 | Günlük |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,10% | 43.269 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,10% | 21.990 SH | 19 Ağustos 2026 | Günlük |
| LGDX · Tidal Trust III | 0,10% | 497 NS | 31 Temmuz 2026 | N-PORT |
| TILT · FlexShares Trust | 0,09% | 7.268 NS | 31 Temmuz 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,09% | 2.686 SH | 01 Ekim 2026 | Günlük |
| PHDG · Invesco Actively Managed Exchange-T… | 0,09% | 209 SH | 01 Ekim 2026 | Günlük |
| HCMT · Direxion Shares ETF Trust | 0,09% | 1.842 NS | 31 Temmuz 2026 | N-PORT |
| TOK · iShares Trust | 0,09% | 744 SH | 11 Eylül 2026 | Günlük |
| SPXL · Direxion Shares ETF Trust | 0,09% | 20.684 NS | 31 Temmuz 2026 | N-PORT |
| URTH · iShares, Inc. | 0,08% | 23.813 SH | 11 Eylül 2026 | Günlük |
| LRGF · iShares Trust | 0,08% | 10.058 SH | 11 Eylül 2026 | Günlük |
| ACWI · iShares Trust | 0,07% | 83.068 SH | 11 Eylül 2026 | Günlük |
| USCL · iShares Trust | 0,07% | 6.976 SH | 11 Eylül 2026 | Günlük |
| NULC · Nushares ETF Trust | 0,06% | 152 NS | 31 Temmuz 2026 | N-PORT |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,06% | 219.986 SH | 19 Ağustos 2026 | Günlük |
| GLOF · iShares Trust | 0,02% | 150 SH | 11 Eylül 2026 | Günlük |
| PEVC · Pacer Funds Trust | 0,01% | 1 NS | 31 Temmuz 2026 | N-PORT |
| GTO · Invesco Actively Managed Exchange-T… | 0,00% | 109.800 | 01 Ekim 2026 | Günlük |
| GTOS · Invesco Actively Managed Exchange-T… | 0,00% | 400 | 30 Eylül 2026 | Günlük |
| BIV · VANGUARD BOND INDEX FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| BLV · VANGUARD BOND INDEX FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| BND · VANGUARD BOND INDEX FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| VUSB · VANGUARD BOND INDEX FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| VCIT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| VCLT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | 30 Temmuz 2026 | Günlük |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | 30 Temmuz 2026 | Günlük |
| VCEB · VANGUARD WORLD FUND | · | · | 30 Temmuz 2026 | Günlük |
CI Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
12 Aylık Fiyat Hedefi
24 analist · 2026-10-02Ortalama hedef $342.29 +26,5%
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| CI | $72.51B | 12.4 | 11.2% | 2.2% | 14.4% | · |
| CVS | $100.87B | 57.1 | 7.8% | 0.44% | 2.4% | · |
| DGX | $19.09B | 19.8 | 11.8% | 9.0% | 14.2% | · |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| GH | $13.34B | -30.8 | 32.9% | -42.4% | 205.7% | · |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| BTSG | $7.20B | 43.0 | 28.2% | 1.5% | 10.8% | 11.8% |
| DVA | $7.79B | 11.5 | 6.5% | 5.5% | -281.8% | · |
| HNGE | $0 | -6.0 | 50.6% | -89.9% | -299.8% | 79.7% |
| HIMS | · | 63.7 | 59.0% | 5.5% | 23.3% | 73.8% |
| CHE | · | 23.3 | 4.1% | 10.5% | 24.4% | · |
Son Haberler Bu şirketten bahseden son manşetler
İşlem Sinyalleri Giriş fiyatı ve risk/ödül oranı ile son alım/satım sinyalleri
Şu anda açık sinyal yok — hiçbir kart dolu değil ve bu dürüstçe.
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.